IM Therapeutics locks in $10 mln Series A

Woburn, Massachusetts-based ImmunoMolecular Therapeutics, a developer of personalized therapies for autoimmune disease, has raised $10 million in Series A financing. JDRF T1D Fund and Morningside Ventures led the round with participation from the Colorado University Healthcare Innovation Fund.

Source: Press Release